American college of chest physicians consensus statement on the management of dyspnea in patients with advanced lung or heart disease

Chest

Volumn 137, Issue 3, 2010, Pages 674-691

  Mahler, Donald A ^a   Selecky, Paul A ^b   Harrod, Christopher G ^c   Benditt, Joshua O ^d   Carrieri Kohlman, Virginia ^e   Curtis, J Randall ^f   Manning, Harold L ^a   Mularski, Richard A ^g   Varkey, Basil ^h   Campbell, Margaret ⁱ   Carter, Edward R ^j   Chiong, Jun Ratunil ^k   Ely, E Wesley ^l   Hansen Flaschen, John ^m   O'Donnell, Denis E ⁿ   Waller, Alexander ^o  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b Hoag Hospital   (United States)

^c American College of Chest Physicians   (United States)

^d UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g KAISER PERMANENTE   (United States)

^h FROEDTERT MEMORIAL LUTHERAN HOSPITAL   (United States)

ⁱ DETROIT RECEIVING HOSPITAL   (United States)

^j SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^k UNIVERSITY OF FLORIDA   (United States)

^l VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

ⁿ QUEEN S UNIVERSITY   (Canada)

^o SHEBA MEDICAL CENTER   (Israel)

more..

Author keywords

[No Author keywords available]

Indexed keywords

COLLEGE; CONFERENCE PAPER; DYSPNEA; HEALTH CARE PERSONNEL; HEART DISEASE; HUMAN; HYPOXEMIA; LUNG DISEASE; OXYGEN THERAPY; PHYSICIAN; PRIORITY JOURNAL; RELAXATION TRAINING; TERMINAL CARE;

EID: 77949505890     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.09-1543     Document Type: Conference Paper

References (103)

1. Lanken PN, Terry PB, Delisser HM, et al; ATS End-of-Life Care Task Force. An official American Thoracic Society clinical policy statement: palliative care for patients with respiratory diseases and critical illnesses. Am J Respir Crit Care Med. 2008;177(8):912-927.
2. Bausewein C, Farquhar M, Booth S, Gysels M, Higginson IJ. Measurement of breathlessness in advanced disease: a systematic review. Respir Med. 2007;101(3):399-410.
3. Edmonds P, Karlsen S, Khan S, Addington-Hall J. A comparison of the palliative care needs of patients dying from chronic respiratory diseases and lung cancer. Palliat Med. 2001;15(4):287-295.
4. Lynn J, Ely EW, Zhong Z, et al. Living and dying with chronic obstructive pulmonary disease. J Am Geriatr Soc. 2000;48(5)(Suppl):S91-S100.
5. Claessens MT, Lynn J, Zhong Z, et al. Dying with lung cancer or chronic obstructive pulmonary disease: insights from SUPPORT. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. J Am Geriatr Soc. 2000;48(5)(Suppl):S146-S153.
6. Banzett RB, Mossavi S. Dyspnea and pain: similarities and contrasts between two very unpleasant sensations. APS Bulletin. 2001;11(1):1-8.
7. von Leupoldt A, Dahme B. Psychological aspects in the perception of dyspnea in obstructive pulmonary diseases. Respir Med. 2007;101(3):411-422.
8. Gilbert CR, Smith CM. Advanced lung disease: quality of life and role of palliative care. Mt Sinai J Med. 2009;76(1): 63-70.
9. Hasson F, Spence A, Waldron M, et al. I can not get a breath: experiences of living with advanced chronic obstructive pulmonary disease. Int J Palliat Nurs. 2008;14(11): 526-531.
10. Pantilat SZ, Isaac M. End-of-life care for the hospitalized patient. Med Clin North Am. 2008;92(2):349-370, viii-ix.
11. Spence A, Hasson F, Waldron M, et al. Professionals delivering palliative care to people with COPD: qualitative study. Palliat Med. 2009;23(2):126-131.
12. Dalkey N, Helmer O. An Experimental Application of the Delphi Method to the Use of Experts. Publication RM-727-PR. Santa Monica, CA: Rand Corporation;1962.
13. Broomfield D, Humphris GM. Using the Delphi technique to identify the cancer education requirements of general practitioners. Med Educ. 2001;35(10):928-937.
14. Lawrence PF, Alexander RH, Bell RM, et al. Determining the content of a surgical curriculum. Surgery. 1983;94(2):309-317.
15. Prasad SA, Main E, Dodd ME; Association of Chartered Physiotherapists. Finding consensus on the physiotherapy management of asymptomatic infants with cystic fibrosis. Pediatr Pulmonol. 2008;43(3):236-244.
16. Dalkey NC, Helmer-Hirschberg O. An Experimental Application of the Delphi Method to the Use of Experts. Publication RM-727-PR. Santa Monica, CA: Rand Corporation; July 1962.
17. Hasson F, Keeney S, McKenna H. Research guidelines the Delphi survey technique. J Adv Nurs. 2000;32(4):1008-1015.
18. Hill K, Fowles J. The methodological worth of the Delphi forecasting technique. Technol Forecast Soc Change. 1975;7(2):179-192.
19. Jones J, Hunter D. Consensus methods for medical and health services research. BMJ. 1995;311 : 376-380.
20. Murray W, Jarmon B. Predicting future trends in adult fitness using the Delphi approach. Res Q Exerc Sport. 1987;58(2):124-131.
21. Miller L. Determining what could/should be: The Delphi technique and its application. Paper presented at: 2006 Annual Meeting of the Mid-Western Educational Research Association. October 2006; Columbus, OH.
22. Brown AK, O'Connor PJ, Roberts TE, Wakefield RJ, Karim Z, Emery P. Recommendations for musculoskeletal ultrasonography by rheumatologists: setting global standards for best practice by expert consensus. Arthritis Rheum. 2005;53(1):83-92.
23. American Thoracic Society. Dyspnea. Mechanisms, assessment, and management: a consensus statement. Am J Respir Crit Care Med. 1999;159(1):321-340.
24. American Academy of Hospice and Palliative Medicine; Center to Advance Palliative Care; Hospice and Palliative Nurses Association; Last Acts Partnership; National Hospice and Palliative Care Organization. National Consensus Project for Quality Palliative Care: clinical practice guidelines for quality palliative care, executive summary. J Palliat Med. 2004;7(5):611-627.
25. WS6-Integrating Palliative Care Into Clinical Practice. The New ATS Clinical Policy Statement [CD-ROM]. New York, NY: American Thoracic Society; 2007.
26. Carrieri-Kohlman V, Dudgeon D. Multidimensional Assessment of Dyspnea in Advanced Disease. New York, NY: Oxford University Press; 2006.
27. Lorenz K, Lynn J, Morton SC, et al. End-of-Life Care and Outcomes. Summary, Evidence Report/Technology Assessment: Number 110. AHRQ Publication number 05-E004-1. Rockville, MD: Agency for Healthcare Research and Quality; 2004.
28. Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest. 1988;93(3):580-586.
29. Mularski RA, Curtis JR, Billings JA, et al. Proposed quality measures for palliative care in the critically ill: a consensus from the Robert Wood Johnson Foundation Critical Care Workgroup. Crit Care Med. 2006;34(11) (Suppl):S404-S411.
30. Selecky PA, Eliasson CA, Hall RI, Schneider RF, Varkey B, McCaffree DR; American College of Chest Physicians. Palliative and end-of-life care for patients with cardiopulmonary diseases: American College of Chest Physicians position statement. Chest. 2005;128(5):3599-3610.
31. Mularski RA, Osborne ML. Palliative care and intensive care unit care: preadmission assessment #122. J Palliat Med. 2006;9(5):1204-1205.
32. Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14(5):377-381.
33. Dudgeon DJ, Kristjanson L, Sloan JA, Lertzman M, Clement K. Dyspnea in cancer patients: prevalence and associated factors. J Pain Symptom Manage. 2001;21(2):95-102.
34. Gift AG. Validation of a vertical visual analogue scale as a measure of clinical dyspnea. Rehabil Nurs. 1989;14(6): 323-325.
35. Gift AG, Narsavage G. Validity of the numeric rating scale as a measure of dyspnea. Am J Crit Care. 1998;7(3):200-204.
36. Higginson IJ, McCarthy M. Validity of the support team assessment schedule: do staffs' ratings reflect those made by patients or their families? Palliat Med. 1993;7(3):219-228.
37. Powers J, Bennett SJ. Measurement of dyspnea in patients treated with mechanical ventilation. Am J Crit Care. 1999; 8(4):254-261.
38. Mahler DA, Jones PW. Measurement of dyspnea and quality of life in advanced lung disease. Clin Chest Med. 1997;18(3):457-469.
39. Nocturnal Oxygen Therapy Trial Group. Continuous or noc turnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Intern Med. 1980;93(3): 391-398.
40. Report of the Medical Research Council Working Party. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet. 1981;1(8222):681-686.
41. Liss HP, Grant BJ. The effect of nasal flow on breathlessness in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1988;137(6):1285-1288.
42. Swinburn CR, Mould H, Stone TN, Corris PA, Gibson GJ. Symptomatic benefit of supplemental oxygen in hypoxemic patients with chronic lung disease. Am Rev Respir Dis. 1991;143(5 Pt 1):913-915.
43. O'Donnell DE, D'Arsigny C, Webb KA. Effects of hyperoxia on ventilatory limitation during exercise in advanced chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;163(4):892-898.
44. Booth S, Wade R, Johnson M, Kite S, Swannick M, Anderson H; Expert Working Group of the Scientific Committee of the Association of Palliative Medicine. The use of oxygen in the palliation of breathlessness. A report of the expert working group of the Scientific Committee of the Association of Palliative Medicine. Respir Med. 2004;98(1):66-77.
45. Alvisi V, Romanello A, Badet M, Gaillard S, Philit F, Guérin C. Time course of expiratory flow limitation in COPD patients during acute respiratory failure requiring mechanical ventilation. Chest. 2003;123(5):1625-1632.
46. Bianchi R, Gigliotti F, Romagnoli I, et al. Chest wall kinematics and breathlessness during pursed-lip breathing in patients with COPD. Chest. 2004;125(2):459-465.
47. Gift AG, Moore T, Soeken K. Relaxation to reduce dyspnea and anxiety in COPD patients. Nurs Res. 1992;41(4):242-246.
48. Renfroe KL. Effect of progressive relaxation on dyspnea and state anxiety in patients with chronic obstructive pulmonary disease. Heart Lung. 1988;17(4):408-413.
49. Casanova C, Celli BR, Tost L, et al. Long-term controlled trial of nocturnal nasal positive pressure ventilation in patients with severe COPD. Chest. 2000;118(6):1582-1590.
50. Lien TC, Wang JH, Huang SH, Chen SD. Comparison of bilevel positive airway pressure and volume ventilation via nasal or facial masks in patients with severe, stable COPD. Zhonghua Yi Xue Za Zhi (Taipei). 2000;63(7):542-551.
51. Jolliet P, Tassaux D, Thouret JM, Chevrolet JC. Beneficial effects of helium: oxygen versus air: oxygen noninvasive pressure support in patients with decompensated chronic obstructive pulmonary disease. Crit Care Med. 1999;27(11):2422-2429.
52. Clini E, Sturani C, Rossi A, et al; Rehabilitation and Chronic Care Study Group, Italian Association of Hospital Pulmonologists (AIPO). The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients. Eur Respir J. 2002;20(3):529-538.
53. Ries AL, Bauldoff GS, Carlin BW, et al. Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest. 2007;131(5) (Suppl):4S-42S.
54. Kolodziej MA, Jensen L, Rowe B, Sin D. Systematic review of noninvasive positive pressure ventilation in severe stable COPD. Eur Respir J. 2007;30(2):293-306.
55. Curtis JR, Cook DJ, Sinuff T, et al; Society of Critical Care Medicine Palliative Noninvasive Positive Ventilation Task Force. Noninvasive positive pressure ventilation in critical and palliative care settings: understanding the goals of therapy. Crit Care Med. 2007;35(3):932-939.
56. Leung RS, Bradley TD. Long term treatment of refractory congestive heart failure by continuous positive airway pressure. Can J Cardiol. 1999;15(9):1009-1012.
57. Bausewein C, Booth S, Gysels M, et al. Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases. Cochrane Database Syst Rev. 2008;(2):CD005623.
58. Breslin EH. The pattern of respiratory muscle recruitment during pursed-lip breathing. Chest. 1992;101(1):75-78.
59. Mueller RE, Petty TL, Filley GF. Ventilation and arterial blood gas changes induced by pursed lips breathing. J Appl Physiol. 1970;28(6):784-789.
60. Tiep BL, Burns M, Kao D, Madison R, Herrera J. Pursed lips breathing training using ear oximetry. Chest. 1986;90(2): 218-221.
61. Janson-Bjerklie S, Carrieri VK, Hudes M. The sensations of pulmonary dyspnea. Nurs Res. 1986;35(3):154-159.
62. Schwartzstein RM, Lahive K, Pope A, Weinberger SE, Weiss JW. Cold facial stimulation reduces breathlessness induced in normal subjects. Am Rev Respir Dis. 1987;136(1):58-61.
63. Jennings AL, Davies AN, Higgins JP, Gibbs JS, Broadley KE. A systematic review of the use of opioids in the management of dyspnoea. Thorax. 2002;57(11):939-944.
64. LeGrand SB, Khawam EA, Walsh D, Rivera NI. Opioids, respiratory function, and dyspnea. Am J Hosp Palliat Care. 2003;20(1):57-61.
65. Poole PJ, Veale AG, Black PN. The effect of sustained-release morphine on breathlessness and quality of life in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(6 Pt 1):1877-1880.
66. Munck LK, Christensen CB, Pedersen L, Larsen U, Branebjerg PE, Kampmann JP. Codeine in analgesic doses does not depress respiration in patients with severe chronic obstructive lung disease. Pharmacol Toxicol. 1990;66(5):335-340.
67. Abernethy AP, Currow DC, Frith P, Fazekas BS, McHugh A, Bui C. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ. 2003;327(7414):523-528.
68. Allen S, Raut S, Woollard J, Vassallo M. Low dose diamorphine reduces breathlessness without causing a fall in oxygen saturation in elderly patients with end-stage idiopathic pulmonary fibrosis. Palliat Med. 2005;19(2):128-130.
69. Noseda A, Carpiaux JP, Markstein C, Meyvaert A, de Maertelaer V. Disabling dyspnoea in patients with advanced disease: lack of effect of nebulized morphine. Eur Respir J. 1997;10(5):1079-1083.
70. Eaton B, Hall J, MacDonald S. Does nebulized morphine offer symptom relief to patients with disabling dyspnea during end-stage disease? Can Fam Physician. 1999;45:319-320.
71. Graff GR, Stark JM, Grueber R. Nebulized fentanyl for palliation of dyspnea in a cystic fibrosis patient. Respiration. 2004;71(6):646-649.
72. Janahi IA, Maciejewski SR, Teran JM, Oermann CM. Inhaled morphine to relieve dyspnea in advanced cystic fibrosis lung disease. Pediatr Pulmonol. 2000;30(3):257-259.
73. Farncombe M, Chater S. Case studies outlining use of nebulized morphine for patients with end-stage chronic lung and cardiac disease. J Pain Symptom Manage. 1993;8(4):221-225.
74. Cohen SP, Dawson TC. Nebulized morphine as a treatment for dyspnea in a child with cystic fibrosis. Pediatrics. 2002;110(3):e38.
75. Lanuke K, Fainsinger RL, DeMoissac D, Archibald J. Two remarkable dyspneic men: when should terminal sedation be administered? J Palliat Med. 2003;6(2):277-281.
76. Qaseem A, Snow V, Shekelle P, et al; Clinical Efficacy Assessment Subcommittee of the American College of Physicians. Evidence-based interventions to improve the palliative care of pain, dyspnea, and depression at the end of life: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2008;148(2):141-146.
77. Thomas JR, von Gunten CF. Clinical management of dyspnoea. Lancet Oncol. 2002;3(4):223-228.
78. Zebraski SE, Kochenash SM, Raffa RB. Lung opioid receptors: pharmacology and possible target for nebulized morphine in dyspnea. Life Sci. 2000;66(23):2221-2231.
79. Chan JD, Treece PD, Engelberg RA, et al. Narcotic and benzodiazepine use after withdrawal of life support: association with time to death? Chest. 2004;126(1):286-293.
80. Daly BJ, Thomas D, Dyer MA. Procedures used in withdrawal of mechanical ventilation. Am J Crit Care. 1996;5(5):331-338.
81. Stone P, Phillips C, Spruyt O, Waight C. A comparison of the use of sedatives in a hospital support team and in a hospice. Palliat Med. 1997;11(2):140-144.
82. Thorns A, Sykes N. Opioid use in last week of life and implications for end-of-life decision-making. Lancet. 2000; 356(9227):398-399.
83. Jennings AL, Davies AN, Higgins JP, Broadley K. Opioids for the palliation of breathlessness in terminal illness. Cochrane Database Syst Rev. 2001;(4):CD002066.
84. Bar-Or D, Marx JA, Good J. Breathlessness, alcohol, and opiates. N Engl J Med. 1982;306(22):1363-1364.
85. Elkington H, White P, Addington-Hall J, Higgs R, Edmonds P. The healthcare needs of chronic obstructive pulmonary disease patients in the last year of life. Palliat Med. 2005;19(6):485-491.
86. Elkington H, White P, Addington-Hall J, Higgs R, Pettinari C. The last year of life of COPD: a qualitative study of symptoms and services. Respir Med. 2004;98(5):439-445.
87. Blackhall LJ, Murphy ST, Frank G, Michel V, Azen S. Ethnicity and attitudes toward patient autonomy. JAMA. 1995;274(10):820-825.
88. Blackhall LJ, Frank G, Murphy ST, Michel V, Palmer JM, Azen SP. Ethnicity and attitudes towards life sustaining technology. Soc Sci Med. 1999;48(12):1779-1789.
89. Curtis JR, Engelberg RA, Nielsen EL, Au DH, Patrick DL. Patient-physician communication about end-of-life care for patients with severe COPD. Eur Respir J. 2004;24(2): 200-205.
90. Heffner JE, Fahy B, Hilling L, Barbieri C. Attitudes regarding advance directives among patients in pulmonary rehabilitation. Am J Respir Crit Care Med. 1996;154(6 Pt 1): 1735-1740.
91. Knauft E, Nielsen EL, Engelberg RA, Patrick DL, Curtis JR. Barriers and facilitators to end-of-life care communication for patients with COPD. Chest. 2005;127(6): 2188-2196.
92. Curtis JR, Engelberg RA, Wenrich MD, et al. Studying communication about end-of-life care during the ICU family conference: development of a framework. J Crit Care. 2002;17(3):147-160.
93. McCarthy M, Lay M, Addington-Hall J. Dying from heart disease. J R Coll Physicians Lond. 1996;30(4):325-328.
94. Sulmasy DP, Pellegrino ED. The rule of double effect: clearing up the double talk. Arch Intern Med. 1999;159(6): 545-550.
95. Anderson H, Ward C, Eardley A, et al. The concerns of patients under palliative care and a heart failure clinic are not being met. Palliat Med. 2001;15(4):279-286.
96. Au DH, Udris EM, Fihn SD, McDonell MB, Curtis JR. Differences in health care utilization at the end of life among patients with chronic obstructive pulmonary disease and patients with lung cancer. Arch Intern Med. 2006;166(3):326-331.
97. Gore JM, Brophy CJ, Greenstone MA. How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer. Thorax. 2000;55(12): 1000-1006.
98. Heffner JE, Fahy B, Hilling L, Barbieri C. Outcomes of advance directive education of pulmonary rehabilitation patients. Am J Respir Crit Care Med. 1997;155(3):1055-1059.
99. Ahmedzai SH, Muers MF. Supportive Care in Respiratory Disease. London, England: Oxford University Press; 2005.
100. Beattie J, Goodlin S. Supportive Care in Heart Failure. London, England: Oxford University Press; 2008.
101. Benyamin R, Trescot AM, Datta S, et al. Opioid complications and side effects. Pain Physician. 2008;11(2) (Suppl): S105-S120.
102. Horlocker TT, Burton AW, Connis RT, et al; American Society of Anesthesiologists Task Force on Neuraxial Opioids. Practice guidelines for the prevention, detection, and management of respiratory depression associated with neuraxial opioid administration. Anesthesiology. 2009;110(2):218-230.
103. Pattinson KT. Opioids and the control of respiration. Br J Anaesth. 2008;100(6):747-758.